vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and Freshworks Inc. (FRSH). Click either name above to swap in a different company.
ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($268.1M vs $228.6M, roughly 1.2× Freshworks Inc.). ACADIA PHARMACEUTICALS INC runs the higher net margin — 1.4% vs -2.1%, a 3.5% gap on every dollar of revenue. On growth, Freshworks Inc. posted the faster year-over-year revenue change (16.5% vs 9.7%). Over the past eight quarters, Freshworks Inc.'s revenue compounded faster (14.6% CAGR vs 5.3%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Freshworks Inc. is a cloud-based software-as-a-service company, founded in 2010 in Chennai, India. The company provides cloud-based tools for customer relationship management (CRM), IT service management (ITSM), and e-commerce marketing.
ACAD vs FRSH — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $268.1M | $228.6M |
| Net Profit | $3.6M | $-4.8M |
| Gross Margin | — | 84.8% |
| Operating Margin | -1.7% | 11.6% |
| Net Margin | 1.4% | -2.1% |
| Revenue YoY | 9.7% | 16.5% |
| Net Profit YoY | — | -268.9% |
| EPS (diluted) | $0.02 | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $268.1M | $228.6M | ||
| Q4 25 | $284.0M | $222.7M | ||
| Q3 25 | $278.6M | $215.1M | ||
| Q2 25 | $264.6M | $204.7M | ||
| Q1 25 | $244.3M | $196.3M | ||
| Q4 24 | $259.6M | $194.6M | ||
| Q3 24 | $250.4M | $186.6M | ||
| Q2 24 | $242.0M | $174.1M |
| Q1 26 | $3.6M | $-4.8M | ||
| Q4 25 | $273.6M | $191.4M | ||
| Q3 25 | $71.8M | $-4.7M | ||
| Q2 25 | $26.7M | $-1.7M | ||
| Q1 25 | $19.0M | $-1.3M | ||
| Q4 24 | $143.7M | $-21.9M | ||
| Q3 24 | $32.8M | $-30.0M | ||
| Q2 24 | $33.4M | $-20.2M |
| Q1 26 | — | 84.8% | ||
| Q4 25 | 90.8% | 85.6% | ||
| Q3 25 | 92.2% | 84.7% | ||
| Q2 25 | 92.2% | 84.8% | ||
| Q1 25 | 91.7% | 84.8% | ||
| Q4 24 | 91.6% | 84.9% | ||
| Q3 24 | 92.5% | 84.0% | ||
| Q2 24 | 92.5% | 83.8% |
| Q1 26 | -1.7% | 11.6% | ||
| Q4 25 | 6.1% | 17.8% | ||
| Q3 25 | 12.8% | -3.5% | ||
| Q2 25 | 12.2% | -4.2% | ||
| Q1 25 | 7.9% | -5.3% | ||
| Q4 24 | 59.1% | -12.2% | ||
| Q3 24 | 12.6% | -20.8% | ||
| Q2 24 | 12.6% | -25.1% |
| Q1 26 | 1.4% | -2.1% | ||
| Q4 25 | 96.3% | 86.0% | ||
| Q3 25 | 25.8% | -2.2% | ||
| Q2 25 | 10.1% | -0.8% | ||
| Q1 25 | 7.8% | -0.7% | ||
| Q4 24 | 55.4% | -11.3% | ||
| Q3 24 | 13.1% | -16.1% | ||
| Q2 24 | 13.8% | -11.6% |
| Q1 26 | $0.02 | $-0.02 | ||
| Q4 25 | $1.61 | $0.66 | ||
| Q3 25 | $0.42 | $-0.02 | ||
| Q2 25 | $0.16 | $-0.01 | ||
| Q1 25 | $0.11 | $0.00 | ||
| Q4 24 | $0.86 | $-0.07 | ||
| Q3 24 | $0.20 | $-0.10 | ||
| Q2 24 | $0.20 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $548.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $1.0B |
| Total Assets | $1.6B | $1.6B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $548.2M | ||
| Q4 25 | $177.7M | $781.4M | ||
| Q3 25 | $258.0M | $813.2M | ||
| Q2 25 | $253.6M | $926.2M | ||
| Q1 25 | $217.7M | $995.3M | ||
| Q4 24 | $319.6M | $1.1B | ||
| Q3 24 | $155.1M | $1.1B | ||
| Q2 24 | $177.1M | $1.0B |
| Q1 26 | — | $1.0B | ||
| Q4 25 | $1.2B | $1.0B | ||
| Q3 25 | $917.3M | $851.5M | ||
| Q2 25 | $822.4M | $984.6M | ||
| Q1 25 | $765.2M | $1.1B | ||
| Q4 24 | $732.8M | $1.1B | ||
| Q3 24 | $577.2M | $1.1B | ||
| Q2 24 | $516.7M | $1.1B |
| Q1 26 | $1.6B | $1.6B | ||
| Q4 25 | $1.6B | $1.6B | ||
| Q3 25 | $1.3B | $1.4B | ||
| Q2 25 | $1.2B | $1.5B | ||
| Q1 25 | $1.1B | $1.5B | ||
| Q4 24 | $1.2B | $1.6B | ||
| Q3 24 | $976.9M | $1.6B | ||
| Q2 24 | $914.1M | $1.5B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $62.4M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $62.4M | ||
| Q4 25 | $-48.7M | $62.3M | ||
| Q3 25 | $74.3M | $63.5M | ||
| Q2 25 | $64.0M | $58.6M | ||
| Q1 25 | $20.3M | $58.0M | ||
| Q4 24 | $40.4M | $41.4M | ||
| Q3 24 | $63.2M | $42.3M | ||
| Q2 24 | $25.0M | $36.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | $60.1M | ||
| Q3 25 | $73.9M | $61.7M | ||
| Q2 25 | — | $58.2M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $36.3M | ||
| Q3 24 | $63.2M | $41.3M | ||
| Q2 24 | — | $34.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | 27.0% | ||
| Q3 25 | 26.5% | 28.7% | ||
| Q2 25 | — | 28.4% | ||
| Q1 25 | — | 28.9% | ||
| Q4 24 | — | 18.7% | ||
| Q3 24 | 25.2% | 22.1% | ||
| Q2 24 | — | 19.5% |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.0% | ||
| Q3 25 | 0.1% | 0.8% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.7% | ||
| Q4 24 | — | 2.6% | ||
| Q3 24 | 0.0% | 0.6% | ||
| Q2 24 | — | 1.3% |
| Q1 26 | — | — | ||
| Q4 25 | -0.18× | 0.33× | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 2.40× | — | ||
| Q1 25 | 1.07× | — | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 1.93× | — | ||
| Q2 24 | 0.75× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
